Work

Satisfaction and Convenience of Chelation Therapy in Patients with Sickle Cell Disease (SCD): Comparison between Deferasirox (Exjade®, ICL670) and Deferoxamine (DFO).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.2334.2334

Authors: E. Vichinsky, R. Fischer, Z. Pakbaz, O. Onyekwere, J. Porter, P. Swerdlow, T. Coates, P. Lane, B. Files, B.U. Mueller, L. Coïc, G. Forni, L. Abetz, J.F. Baladi, C. Ressayre-Djaffer, I. Gathmann, D. Alberti, P. Marks

Institutions: Howard University, University College London, The Barbara Ann Karmanos Cancer Institute, Children's Hospital Los Angeles, Emory University, Children's Healthcare of Atlanta, Baylor College of Medicine, Hôpital Intercommunal de Créteil, Ente Ospedaliero Ospedali Galliera

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2992562855

FWCI: 1.184

Cites:

Cited by: 12

Related to: 10